Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony C Faber

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|September 9, 2023
Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer TreatmentVictoria Neely, Alekhya Manchikalapudi, Khanh Nguyen, et al.
Biochemical Pharmacology|September 18, 2021
Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapyValerie Carpenter, Tareq Saleh, So Min Lee, et al.
Oncogene|January 20, 2018
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersHiroshi Kotani, Yuta Adachi, Hidenori Kitai, et al.
Cancer Discovery|May 8, 2016
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung CancerHidenori Kitai, Hiromichi Ebi, Shuta Tomida, et al.
Biochemical Pharmacology|June 23, 2024
Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancerValerie Carpenter, Tareq Saleh, Eesha Chakraborty, et al.
Molecular Pharmacology|December 15, 2021
Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by CisplatinFereshteh Ahmadinejad, Tasia Bos, Bin Hu, et al.
Cell Stress|February 17, 2022
MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in <i>MYCN</i>-amplified neuroblastomaKonstantinos V Floros, Ayesha T Chawla, Mia O Johnson-Berro, et al.
Bioinformatics (Oxford, England)|March 14, 2026
Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative ApproachesBrydon P G Wall, Jonathan D Ogata, My Nguyen, et al.
The Journal of Clinical Investigation|June 24, 2008
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteinsMarta Guix, Anthony C Faber, Shizhen Emily Wang, et al.
Cell Death & Disease|February 16, 2021
Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitorsKonstantinos V Floros, Sheeba Jacob, Richard Kurupi, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|September 9, 2023
Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer TreatmentVictoria Neely, Alekhya Manchikalapudi, Khanh Nguyen, et al.
Biochemical Pharmacology|September 18, 2021
Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapyValerie Carpenter, Tareq Saleh, So Min Lee, et al.
Oncogene|January 20, 2018
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersHiroshi Kotani, Yuta Adachi, Hidenori Kitai, et al.
Cancer Discovery|May 8, 2016
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung CancerHidenori Kitai, Hiromichi Ebi, Shuta Tomida, et al.
Biochemical Pharmacology|June 23, 2024
Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancerValerie Carpenter, Tareq Saleh, Eesha Chakraborty, et al.
Molecular Pharmacology|December 15, 2021
Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by CisplatinFereshteh Ahmadinejad, Tasia Bos, Bin Hu, et al.
Cell Stress|February 17, 2022
MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in <i>MYCN</i>-amplified neuroblastomaKonstantinos V Floros, Ayesha T Chawla, Mia O Johnson-Berro, et al.
Bioinformatics (Oxford, England)|March 14, 2026
Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative ApproachesBrydon P G Wall, Jonathan D Ogata, My Nguyen, et al.
The Journal of Clinical Investigation|June 24, 2008
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteinsMarta Guix, Anthony C Faber, Shizhen Emily Wang, et al.
Cell Death & Disease|February 16, 2021
Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitorsKonstantinos V Floros, Sheeba Jacob, Richard Kurupi, et al.
Pageof 8